Cengild Medical Berhad (KLSE:CENGILD)
Malaysia flag Malaysia · Delayed Price · Currency is MYR
0.1900
-0.0050 (-2.56%)
At close: Jul 28, 2026

Cengild Medical Berhad Cash Flow Statement

Millions MYR. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Income
9.4111.0611.0813.299.3910
Depreciation & Amortization
5.926.54.013.174.414.86
Other Amortization
---0.151.27-
Loss (Gain) From Sale of Assets
0.60.6----
Asset Writedown & Restructuring Costs
0.030.0100.010-
Loss (Gain) on Equity Investments
-0.91-0.470.35--0
Stock-Based Compensation
0.090.180.260.390.09-
Provision & Write-off of Bad Debts
0.490.4900.030-
Other Operating Activities
-3.04-0.03-1.42-2.31-1.251.05
Change in Accounts Receivable
0.4-5.17-1.66-0.3-0.89-1.19
Change in Inventory
0.1-0.48-0.34-0.23-0.21-0.17
Change in Accounts Payable
-3.265.671.53-0.282.380.82
Change in Other Net Operating Assets
-0.080.030-0.010.13-1.07
Operating Cash Flow
9.1116.0812.9413.9115.3314.3
Operating Cash Flow Growth
-69.67%24.30%-7.02%-9.24%7.21%27.22%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Capital Expenditures
-71.57-37.26-15.73-2.13-0.43-1.7
Sale of Property, Plant & Equipment
0.060.130.39---
Cash Acquisitions
----0-
Divestitures
-0.05-0.05----
Investment in Securities
12.4713.41-67.4550-48-2
Other Investing Activities
34.013.143.362.780.50.06
Investing Cash Flow
-25.08-20.63-79.4350.65-47.93-3.64

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Long-Term Debt Issued
-25.69----
Short-Term Debt Repaid
-----2.02-4
Long-Term Debt Repaid
--2.45-1.7-1.27-0.96-0.74
Total Debt Repaid
-2.41-2.45-1.7-1.27-2.98-4.74
Net Debt Issued (Repaid)
33.9923.24-1.7-1.27-2.98-4.74
Issuance of Common Stock
--0.015.6372.2-
Common Dividends Paid
-5.83-8.08-6.16-6.06--7.28
Other Financing Activities
-0.18-0.29-0.6-0.94-4.470.05
Financing Cash Flow
27.9714.87-8.45-2.6564.76-11.98

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Cash Flow
1210.32-74.9461.9232.16-1.32

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Free Cash Flow
-62.46-21.18-2.811.7814.912.6
Free Cash Flow Growth
----20.92%18.27%18.55%
Free Cash Flow Margin
-85.39%-26.48%-4.19%16.77%23.12%19.85%
Free Cash Flow Per Share
-0.07-0.03-0.000.010.020.02
Levered Free Cash Flow
-63.89-20.63-3.29.3813.49.72
Unlevered Free Cash Flow
-63.72-20.39-2.829.8413.9310.48

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash Interest Paid
0.180.290.60.70.851.22
Cash Income Tax Paid
5.094.264.334.344.323.57
Change in Working Capital
-2.850.05-0.46-0.821.41-1.62